#drabhishekshukla #trending #icu #injection #adrenaline #noradrenaline #vasopressin #lowbp #neet #bp
Dr. Abhishek Shukla- Aastha Old Age Hospital
0:00 / 0:00
#drabhishekshukla #trending #icu #injection #adrenaline #noradrenaline #vasopressin #lowbp #neet #bp
75 746 просмотров · 1 г. назад
Dr. Abhishek Shukla- Aastha Old Age Hospital
406 тыс. подписчиков
75 746 просмотров · 1 г. назад
Dr. Abhishek Shukla discussed three commonly used vasoactive drugs in the ICU. Adrenaline, Noradrenaline, and Vasopressin that play a critical role in the management of critically ill patients. These drugs are especially vital during states of circulatory shock, where the body’s ability to maintain adequate blood pressure and tissue perfusion is compromised. Each drug works through a different mechanism, targeting specific receptors in the body to stabilize cardiovascular function.
Adrenaline (also known as epinephrine) is a potent agent that acts on both alpha and beta adrenergic receptors. It increases heart rate, cardiac output, and causes vasoconstriction, making it useful in cardiac arrest, anaphylaxis, and severe hypotension. Noradrenaline (norepinephrine), on the other hand, primarily stimulates alpha receptors leading to intense vasoconstriction, which raises systemic vascular resistance and blood pressure. It is often the first-line agent in septic shock.
Vasopressin, unlike the catecholamines, acts on V1 receptors in the blood vessels to cause vasoconstriction and helps restore vascular tone in vasodilatory shock states, particularly when patients are unresponsive to noradrenaline alone. Together, these three agents are essential tools in ICU resuscitation protocols, helping stabilize patients who present with low blood pressure, high heart rates, poor cardiac output, or shock due to various underlying causes.
#AasthaCares #ICUCare #VasoactiveDrugs #Adrenaline #Noradrenaline #Vasopressin #CriticalCareMedicine #ShockManagement #LowBP #CardiacSupport #DrAbhishekShukla #IntensiveCare #Resuscitation #EmergencyMedicine #SepsisCare #HeartSupport #LifeSavingDrugs